Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1

Mirko Völkers, Haruhiro Toko, Shirin Doroudgar, Shabana Din, Pearl Quijada, Anya Y. Joyo, Luis Ornelas, Eri Joyo, Donna J. Thuerauf, Mathias H. Konstandin, Natalie Gude, Christopher C. Glembotski, Mark A. Sussman

Research output: Contribution to journalArticlepeer-review

89 Scopus citations

Fingerprint

Dive into the research topics of 'Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases